Central Asia vs Ecuador: Proportion of the target population who received the final dose of
Central Asia
59.0%
in 2024
Ecuador
89.0%
in 2024
Central Asia rank
8th
Ecuador rank
11th
Proportion of the target population who received the final dose of over time
- Central Asia
- Ecuador
How they compare
Ecuador currently reports 89.0% against 59.0% in Central Asia, a difference of 30.0%.
That makes Ecuador's figure about 1.5 times Central Asia's.
The two have swapped places 4 times across 8 shared years of data; in 2017 it was Ecuador ahead.
Central Asia ranks 8th and Ecuador ranks 11th of 35 groups.
Across the 2 decades both report, Central Asia averaged higher in 1 and Ecuador in 1.
Head to head by decade
| Decade | Central Asia | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.0% | 70.7% | 62.7% | Ecuador |
| 2020s | 52.0% | 45.8% | 6.2% | Central Asia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Central Asia or Ecuador?
- Ecuador, at 89.0% against 59.0% in Central Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Central Asia and Ecuador?
- 30.0%, with Ecuador ahead.
- How many years of comparable data are there for Central Asia and Ecuador?
- 8 years are reported by both, from 2017 to 2024.
- How do Central Asia and Ecuador rank globally for proportion of the target population who received the final dose of?
- Central Asia ranks 8th and Ecuador ranks 11th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.